Data / Form D filings / Relay Therapeutics, Inc.
Relay Therapeutics, Inc.: Form D filing
Relay Therapeutics, Inc., a pharmaceuticals company in Cambridge, MA, filed a Form D with the SEC in 2024. The latest, on January 10, 2024, reports $30 million sold of a $30 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 399 BINNEY STREET, 2ND FLOOR, Cambridge, MA, 02139
- Phone
- (617) 370-8837
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1812364
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | New notice | $30,000,000 | $30,000,000 | 1 | Jan 10, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas A. Catinazzo | Executive Officer | |
| Peter A. Rahmer | Executive Officer | |
| Sekar S. Kathiresan | Director | |
| Douglas S. Ingram | Director | |
| Sanjiv K. Patel | Executive Officer, Director | |
| Mark S. Murcko | Director | |
| Laura S. Shawver | Director | |
| Brian K. Adams | Executive Officer | |
| Linda A. Hill | Director | |
| Jami S. Rubin | Director | |
| Donald A. Bergstrom | Executive Officer | |
| Alexis A. Borisy | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jan 8, 2024 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Relay Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.